Lori Panther

2.2k total citations · 2 hit papers
40 papers, 1.5k citations indexed

About

Lori Panther is a scholar working on Epidemiology, Infectious Diseases and Surgery. According to data from OpenAlex, Lori Panther has authored 40 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Epidemiology, 20 papers in Infectious Diseases and 12 papers in Surgery. Recurrent topics in Lori Panther's work include Cervical Cancer and HPV Research (13 papers), Colorectal and Anal Carcinomas (8 papers) and Cytomegalovirus and herpesvirus research (8 papers). Lori Panther is often cited by papers focused on Cervical Cancer and HPV Research (13 papers), Colorectal and Anal Carcinomas (8 papers) and Cytomegalovirus and herpesvirus research (8 papers). Lori Panther collaborates with scholars based in United States, Australia and Canada. Lori Panther's co-authors include Tal Zaks, Igor Smolenov, Michael Watson, James D. Thompson, Rainard Fuhr, Hari Pujar, Mike Smith, Joseph J. Senn, Robert Feldman and Giuseppe Ciaramella and has published in prestigious journals such as Annals of Internal Medicine, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

Lori Panther

40 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

mRNA vaccines against H10N8 and H7N9 influenza viruses of pandemic potential are immunogenic and well tolerated in healthy adults in phase 1 randomized clinical trials

2019 331 citations Robert Feldman, Rainard Fuhr et al. Vaccine profile →
Human Cytomegalovirus mRNA-1647 Vaccine Candidate Elicits Potent and Broad Neutralization and Higher Antibody-Dependent Cellular Cytotoxicity Responses Than the gB/MF59 Vaccine

2024 48 citations Xintao Hu, Sarah Valencia et al. The Journal of Infectious Diseases profile →

Peers

Countries citing papers authored by Lori Panther

Since Specialization

Citations

This map shows the geographic impact of Lori Panther's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lori Panther with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lori Panther more than expected).

Fields of papers citing papers by Lori Panther

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lori Panther. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lori Panther. The network helps show where Lori Panther may publish in the future.

Co-authorship network of co-authors of Lori Panther

This figure shows the co-authorship network connecting the top 25 collaborators of Lori Panther. A scholar is included among the top collaborators of Lori Panther based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lori Panther. Lori Panther is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Human Cytomegalovirus mRNA-1647 Vaccine Candidate Elicits Potent and Broad Neutralization and Higher Antibody-Dependent Cellular Cytotoxicity Responses Than the gB/MF59 Vaccine breakdown → 2024 ·The Journal of Infectious Diseases ·Xintao Hu, (unknown), (unknown), Sarah Valencia, Jennifer A. Jenks, (unknown), (unknown), M. Connors, Justin Pollara, Caroline Andy, (unknown), Emmanuel B. Walter, Kathryn M. Edwards, David I. Bernstein, (unknown), Matthew Koch, Lori Panther, Andrea Carfı́, Kaichun Wu, Sallie R. Permar	48
2	A phase 1, randomized, placebo-controlled, dose-ranging study to evaluate the safety and immunogenicity of an mRNA-based chikungunya virus vaccine in healthy adults 2023 ·Vaccine ·Christine A. Shaw, Allison August, Stephan Bart, (unknown), (unknown), Trevor Brasel, Scott C. Weaver, Haiyu Zhou, Lori Panther	23
3	2892. Safety and Immunogenicity of mRNA-1647, an mRNA-Based Cytomegalovirus Vaccine in Healthy Adults: Results of a Phase 2, Randomized, Observer-Blind, Placebo-Controlled, Dose-Finding Trial 2023 ·Open Forum Infectious Diseases ·Lori Panther, (unknown), Carlos Fierro, Daniel C. Brune, Richard Leggett, James T. Peterson, (unknown), (unknown), Kaichun Wu, Heather Lee, (unknown), (unknown), Jacqueline M. Miller	15
4	Comparison of Overall Sensitivity and Specificity across Different Newborn Screening Algorithms for Congenital Cytomegalovirus 2023 ·International Journal of Neonatal Screening ·Mark R. Schleiss, Lori Panther, (unknown), Meklit Workneh, John Diaz‐Decaro	7
5	A Qualitative Assessment of Clinical Practice Guidelines and Patterns for Congenital Cytomegalovirus in the United States 2023 ·International Journal of Neonatal Screening ·(unknown), John Diaz‐Decaro, (unknown), (unknown), Lori Panther, James A. Mansi, Laura Gibson	2
6	A phase 1, randomized, placebo-controlled study to evaluate the safety and immunogenicity of an mRNA-based RSV prefusion F protein vaccine in healthy younger and older adults 2020 ·Human Vaccines & Immunotherapeutics ·Antonios O. Aliprantis, Christine A. Shaw, Paul Griffin, Nicholas Farinola, Radha Railkar, (unknown), Wen Liu, Jeffrey R. Sachs, (unknown), Heather Lee, Kara S. Cox, Daniel S. Spellman, Colleen J. Winstead, Igor Smolenov, Eseng Lai, Tal Zaks, Amy S. Espeseth, Lori Panther	111
7	mRNA vaccines against H10N8 and H7N9 influenza viruses of pandemic potential are immunogenic and well tolerated in healthy adults in phase 1 randomized clinical trials breakdown → 2019 ·Vaccine ·Robert Feldman, Rainard Fuhr, Igor Smolenov, (unknown), Lori Panther, Michael Watson, Joseph J. Senn, Mike Smith, Örn Almarsson, Hari Pujar, Michael E. Laska, James D. Thompson, Tal Zaks, Giuseppe Ciaramella	331
8	Test performance and acceptability of self- versus provider-collected swabs for high-risk HPV DNA testing in female-to-male trans masculine patients 2018 ·PLoS ONE ·Sari L. Reisner, Madeline B. Deutsch, Sarah M. Peitzmeier, Jaclyn M. W. Hughto, Timothy Cavanaugh, Dana J. Pardee, Sarah McLean, Lori Panther, Marcy Gelman, Matthew J. Mimiaga, Jennifer Potter	72
9	Facilitators of and barriers to HPV vaccination among sexual and gender minority patients at a Boston community health center 2018 ·Vaccine ·(unknown), Holly B. Fontenot, Derri Shtasel, Sannisha K. Dale, Christina P. C. Borba, Christopher S. Lathan, Lori Panther, Kenneth H. Mayer, Alex S. Keuroghlian	46
10	Effects of Different Doses of GEN-003, a Therapeutic Vaccine for Genital Herpes Simplex Virus-2, on Viral Shedding and Lesions: Results of a Randomized Placebo-Controlled Trial 2018 ·The Journal of Infectious Diseases ·Nicholas Van Wagoner, Kenneth H. Fife, Peter A. Leone, David I. Bernstein, Terri Warren, Lori Panther, Richard M. Novak, Richard H. Beigi, John D. Kriesel, Stephen K. Tyring, William Koltun, Gregg Lucksinger, Amy Morris, Bin Zhang, Lisa K. McNeil, Sybil Tasker, Seth Hetherington, Anna Wald	31
11	Adherence and Acceptability of a Multidrug Vaginal Ring for HIV Prevention in a Phase I Study in the United States 2016 ·AIDS and Behavior ·Ariane van der Straten, Lori Panther, Nicole Laborde, Craig Hoesley, Helen Cheng, Marla Husnik, Stephanie Van Horn, Annaléne Nel, Lydia Soto‐Torres, Beatrice A. Chen	32
12	Pharmacodynamic correlations using fresh and cryopreserved tissue following use of vaginal rings containing dapivirine and/or maraviroc in a randomized, placebo controlled trial 2016 ·Medicine ·Charlene S. Dezzutti, Nicola Richardson‐Harman, Lisa C. Rohan, Mark A. Marzinke, Craig Hoesley, Lori Panther, Sherri Johnson, Jeremy Nuttall, Annaléne Nel, Beatrice A. Chen	13
13	Phase 1 Safety, Pharmacokinetics, and Pharmacodynamics of Dapivirine and Maraviroc Vaginal Rings 2015 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Beatrice A. Chen, Lori Panther, Mark A. Marzinke, Craig W. Hendrix, Craig Hoesley, Ariane van der Straten, Marla Husnik, Lydia Soto‐Torres, Annaléne Nel, Sherri Johnson, Nicola Richardson‐Harman, Lorna K. Rabe, Charlene S. Dezzutti	90
14	Effects of a Vaginal Ring Containing Maraviroc and or Dapivirine Worn for 28 Days on the Vaginal Microflora 2014 ·AIDS Research and Human Retroviruses ·Lorna K. Rabe, Leslie A. Meyn, Beatrice A. Chen, Lori Panther, Craig Hoesley, Sharon L. Hillier	4
15	Cost-Effectiveness of Surveillance Strategies After Treatment for High-Grade Anal Dysplasia in High-Risk Patients 2013 ·Sexually Transmitted Diseases ·Sabrina A. Assoumou, Kenneth H. Mayer, Lori Panther, Benjamin P. Linas, Jane J. Kim	8
16	Safety and efficacy of topical cidofovir to treat high-grade perianal and vulvar intraepithelial neoplasia in HIV-positive men and women 2012 ·AIDS ·Elizabeth A. Stier, Stephen E. Goldstone, Mark H. Einstein, Naomi Jay, (unknown), Timothy Wilkin, Jeannette Y. Lee, Teresa M. Darragh, Maria Da Costa, Lori Panther, David M. Aboulafia, Joel M. Palefsky	43
17	High Resolution Anoscopy Findings for Men Who Have Sex with Men: Inaccuracy of Anal Cytology as a Predictor of Histologic High-Grade Anal Intraepithelial Neoplasia and the Impact of HIV Serostatus 2004 ·Clinical Infectious Diseases ·Lori Panther, (unknown), (unknown), (unknown), P A Chatis, (unknown), Imad Nasser, John P. Doweiko, Bruce J. Dezube	120
18	Genital Tract Human Immunodeficiency Virus Type 1 (HIV‐1) Shedding and Inflammation and HIV‐1envDiversity in Perinatal HIV‐1 Transmission 2000 ·The Journal of Infectious Diseases ·Lori Panther, Lynne Tucker, Chuanqing Xu, Ruth Tuomala, James I. Mullins, Deborah J. Anderson	43
19	Unintegrated Circular HIV-1 DNA in the Peripheral Mononuclear Cells of HIV-1-Infected Subjects: Association With High Levels of Plasma HIV-1 RNA, Rapid Decline in CD4 Count, and Clinical Progression to AIDS 1998 ·Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology ·Lori Panther, Robert W. Coombs, Judith E. Zeh, Ann C. Collier, Lawrence Corey	18
20	Acute Infection of Macaca nemestrina by Human Immunodeficiency Virus Type 1 1993 ·Virology ·Lyn R. Frumkin, Michael B. Agy, Robert W. Coombs, Lori Panther, William R. Morton, James K. Koehler, (unknown), Joan Dragavon, Ann Marie Schmidt, Michael G. Katze, Lawrence Corey	36

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact